{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-VB9VS8LW/5996ec98-992a-4474-8c7d-8849434b3d04/PDF","dcterms:extent":"79 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-VB9VS8LW/21cb13ab-8857-4b82-962a-3e197b1d25d5/TEXT","dcterms:extent":"12 KB"}],"edm:TimeSpan":{"@rdf:about":"2005-2025","edm:begin":{"@xml:lang":"en","#text":"2005"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-VB9VS8LW","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN"},{"@xml:lang":"sl","#text":"Farmacevtski vestnik"}],"dcterms:issued":"2015","dc:creator":"Laptoš, Tomislav","dc:format":[{"@xml:lang":"sl","#text":"številka:1"},{"@xml:lang":"sl","#text":"letnik:66"},{"@xml:lang":"sl","#text":"str. 99-102"}],"dc:identifier":["ISSN:0014-8229","COBISSID:2149548","URN:URN:NBN:SI:doc-VB9VS8LW"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko farmacevtsko društvo"},"dc:subject":[{"@xml:lang":"sl","#text":"centralni živčni sistem"},{"@xml:lang":"en","#text":"drug"},{"@xml:lang":"sl","#text":"prehod učinkovin"},{"@xml:lang":"sl","#text":"zdravila"},{"@rdf:resource":"http://www.wikidata.org/entity/Q47273"}],"dcterms:temporal":{"@rdf:resource":"2005-2025"},"dc:title":{"@xml:lang":"sl","#text":"Prehod učinkovin na mesto delovanja v osrednjem živčnem sistemu| Drug delivery to the central nervous system|"},"dc:description":{"@xml:lang":"sl","#text":"Staranje populacije in pričakovana visoka kvaliteta življenja bosta tudi v prihodnje povečevala uporabo zdravil, ki delujejo v centralnem živčnem sistemu. Razvoj novih učinkovin žal ovira tudi slab prehod preko krvno-možganske pregrade, ki onemogoča doseganje farmakološkega učinka. V članku so predstavljeni poglavitni mehanizmi prehoda snovi v osrednje živčevje ter načini modifikacije zdravilne učinkovine in farmacevtske oblike za doseganje boljših kliničnih izidov zdravljenja"},"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-VB9VS8LW","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-VB9VS8LW"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-VB9VS8LW/5996ec98-992a-4474-8c7d-8849434b3d04/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko farmacevtsko društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-VB9VS8LW/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-VB9VS8LW"}}}}